Company Profile

HEPALINK

9989 Drug Manufacturers - Specialty & Generic
Description

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. The company operates through four segments: Finished Dose Pharmaceutical Products, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization, and Others. Its pharmaceutical products consist of finished dose pharmaceutical products, which primarily include enoxaparin sodium injection; API products, including heparin sodium API and enoxaparin sodium API; and other products, such as pancreatin API. The company is also involved in the provision of research and development, manufacturing, quality management, and program management services; and development and manufacture of recombinant pharmaceutical products, critical non-viral vectors, intermediates for gene therapy, and naturally derived pharmaceutical products. In addition, it engages in research, development, production, services, and trading biopharmaceutical; property management, investment management and consulting, biopharmaceutical technology development and consulting, and equity and venture investment activities; production and sale of heparin sodium; provision of services on pharmaceutical related activities; and trading of medical and biopharmaceutical products. The company was formerly known as Shenzhen Hepalink Pharmaceutical Co.,Ltd. and changed its name to Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in February 2017. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. was founded in 1998 and is headquartered in Shenzhen, the People's Republic of China.

Reports

This company has 5 ESG reports available.

ESG Performance Overview

Select a KPI indicator to view performance trend

KPI Indicators

A1.1 Emission Types and Data
9 Data Points
Indicator Data Points Actions
SOₓ Emissions 3
NOₓ Emissions 3
Airborne Particulate Matter (PM) Emissions 3
A1.2 Direct (Scope 1) and Indirect (Scope 2) GHG Emissions
28 Data Points
Indicator Data Points Actions
Total GHG Emissions Intensity (By Revenue) 4
Total GHG Emissions 8
Direct GHG Emissions (Scope 1) 8
Indirect Energy Emissions (Scope 2) 8
A1.3 Hazardous Waste
12 Data Points
Indicator Data Points Actions
Total Hazardous Waste Intensity (By Revenue) 4
Total Hazardous Waste 8
A1.4 Non-Hazardous Waste
14 Data Points
Indicator Data Points Actions
Non-Hazardous Waste Disposed 8
Total Non-Hazardous Waste Intensity (By Unit Product) 2
Total Non-Hazardous Waste Intensity (By Revenue) 4

A2.1 Energy Consumption
50 Data Points
Indicator Data Points Actions
Energy Consumption Intensity (By Revenue) 3
Energy Consumption Intensity (By Unit Product) 1
Direct Energy Intensity (By Unit Product) 1
Indirect Energy Intensity (By Unit Product) 1
Comprehensive Energy Consumption Intensity (By Unit Product) 1
Total Electricity Consumption Intensity (By Unit Product) 1
Total Energy Consumption 6
Total Direct Energy Consumption 6
Total Non-Renewable Fuel Consumption 3
Gasoline Consumption 6
Natural Gas Consumption 5
LPG Consumption 4
Total Indirect Energy Consumption 6
Purchased Electricity 6
A2.2 Water Consumption
10 Data Points
Indicator Data Points Actions
Water Consumption 6
Water Consumption Intensity (By Revenue) 4
A2.5 Total Packaging Material Used
10 Data Points
Indicator Data Points Actions
Packaging Materials Consumed 6
Packaging Material Intensity (By Revenue) 4

B1.1 Amount and Distribution of Workforce
217 Data Points
Indicator Data Points Actions
Number of Total Employees 9
Number of Male Employees 9
Number of Female Employees 9
Percentage of Male Employees 9
Percentage of Female Employees 9
Number of Full-time Employees 9
Number of Part-time Employees 9
Number of Contractors 9
Number of Interns 9
Number of Temporary Workers 8
Percentage of Full-time Employees 9
Percentage of Part-time Employees 9
Percentage of Contractors 9
Percentage of Interns 9
Percentage of Temporary Workers 8
Number of Employees Aged Below 30 9
Number of Employees Aged 30-50 9
Number of Employees Aged Above 50 9
Percentage of Employees Aged Below 30 9
Percentage of Employees Aged 30-50 9
Percentage of Employees Aged Above 50 9
Number of Employees in Mainland China 9
Number of Employees in North America 9
Percentage of Employees in Mainland China 6
Percentage of Employees in North America 6
B1.2 Employee Turnover Rate
44 Data Points
Indicator Data Points Actions
Turnover Rate of Female Employees 8
Turnover Rate of Male Employees 8
Turnover Rate of Employees Aged Below 30 4
Turnover Rate of Employees Aged 30-50 4
Turnover Rate of Employees Aged Above 50 4
Turnover Rate of Employees in Mainland China 8
Turnover Rate of Employees in North America 8

B2.1 Number and Rate of Work-related Fatalities
7 Data Points
Indicator Data Points Actions
Number of Work-related Fatalities 2
Number of Fatalities of the Last 3 Years 5
B2.2 Lost Days Due to Work Injury
5 Data Points
Indicator Data Points Actions
Lost Days Due to Work-related Injuries 5

B3.1 The Percentage of Employees Trained
48 Data Points
Indicator Data Points Actions
Percentage of Employees Trained 3
Percentage of Trained Male Employees 9
Percentage of Trained Female Employees 9
Percentage of Trained Senior Management 9
Percentage of Trained Middle Management 9
Percentage of Trained General Employees 9
B3.2 Average Training Hours Completed per Employee
45 Data Points
Indicator Data Points Actions
Average Training Hours (Male) 9
Average Training Hours (Female) 9
Average Training Hours (Senior Management) 9
Average Training Hours (Middle Management) 9
Average Training Hours (General Staff) 9

B4.2 Eliminate Labour Standards
5 Data Points
Indicator Data Points Actions
Number of Labour-related Complaints 5

B5.1 Number of Suppliers by Geographical Region
10 Data Points
Indicator Data Points Actions
Number of Total Suppliers 4
Number of Suppliers in Mainland China 4
Number of Suppliers in Overseas 2

B6.1 Products Recalled
5 Data Points
Indicator Data Points Actions
Percentage of Recalled Products for Safety and Health Reasons 5
B6.2 Products Complaints
5 Data Points
Indicator Data Points Actions
Number of Products and Service Related Complaints 5

B7.1 Confirmed Incidents of Corruption
5 Data Points
Indicator Data Points Actions
Number of Concluded Corruption Lawsuits 3
Number of Corruption Litigation 2

B8.2 Resources Contributed to the Community
1 Data Points
Indicator Data Points Actions
Total Social Investment 1